Business Description
CompuGroup Medical SE & Co KgaA
NAICS : 541511
ISIN : DE000A288904
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.08 | |||||
Equity-to-Asset | 0.35 | |||||
Debt-to-Equity | 1.15 | |||||
Debt-to-EBITDA | 3.6 | |||||
Interest Coverage | 5.06 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.55 | |||||
Beneish M-Score | -2.78 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 13.3 | |||||
3-Year EBITDA Growth Rate | 4.2 | |||||
3-Year EPS without NRI Growth Rate | 2.7 | |||||
3-Year FCF Growth Rate | 5 | |||||
3-Year Book Growth Rate | 2.5 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 42.37 | |||||
9-Day RSI | 49.1 | |||||
14-Day RSI | 48.83 | |||||
6-1 Month Momentum % | -25.53 | |||||
12-1 Month Momentum % | -44.27 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.07 | |||||
Quick Ratio | 1.01 | |||||
Cash Ratio | 0.19 | |||||
Days Inventory | 46.19 | |||||
Days Sales Outstanding | 55.59 | |||||
Days Payable | 180.47 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.7 | |||||
Dividend Payout Ratio | 0.24 | |||||
Forward Dividend Yield % | 3.41 | |||||
5-Year Yield-on-Cost % | 2.19 | |||||
3-Year Average Share Buyback Ratio | 0.9 | |||||
Shareholder Yield % | 3.92 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 84.63 | |||||
Operating Margin % | 10.35 | |||||
Net Margin % | 3.87 | |||||
FCF Margin % | 8.77 | |||||
ROE % | 6.76 | |||||
ROA % | 2.38 | |||||
ROIC % | 4.44 | |||||
ROC (Joel Greenblatt) % | 60.31 | |||||
ROCE % | 6.26 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 31.93 | |||||
PE Ratio without NRI | 14.11 | |||||
Shiller PE Ratio | 22.21 | |||||
Price-to-Owner-Earnings | 19.9 | |||||
PEG Ratio | 4.03 | |||||
PS Ratio | 1.28 | |||||
PB Ratio | 2.27 | |||||
Price-to-Free-Cash-Flow | 14.61 | |||||
Price-to-Operating-Cash-Flow | 8.49 | |||||
EV-to-EBIT | 22.89 | |||||
EV-to-EBITDA | 10.43 | |||||
EV-to-Revenue | 1.87 | |||||
EV-to-FCF | 21.33 | |||||
Price-to-Projected-FCF | 0.97 | |||||
Price-to-DCF (Earnings Based) | 0.42 | |||||
Price-to-DCF (FCF Based) | 0.42 | |||||
Price-to-Median-PS-Value | 0.37 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.33 | |||||
Earnings Yield (Greenblatt) % | 4.37 | |||||
FCF Yield % | 6.86 | |||||
Forward Rate of Return (Yacktman) % | 11.54 |